Sysmex Corporation

Sysmex Corporation is a Kobe, Japan-based in vitro diagnostics company founded in 1968 that is the global market leader in automated hematology analyzers, coagulation testing systems, and clinical laboratory informatics, with a growing presence in urinalysis, microbiology, and molecular diagnostics. Sysmex's XN-Series and XE-Series automated hematology analyzers are the dominant instruments in clinical laboratories worldwide for complete blood count analysis, providing white blood cell differential counts, reticulocyte analysis, body fluid analysis, and immature granulocyte flagging from minimal blood volumes with exceptional precision. For research applications, Sysmex's analyzers generate high-parameter CBC data with additional scattergram information that enables researchers to detect subtle changes in blood cell morphology and function in hematological disease, chemotherapy response studies, and population-level epidemiological research. The Sysmex HISCL automated immunoassay analyzer provides chemiluminescent immunoassay testing for hepatitis B and C, HIV, cardiac biomarkers, and tumor markers used in large-scale biobanking studies. Sysmex's CS-Series coagulation analyzers, including the CS-5100 and CS-2500, perform comprehensive coagulation testing for PT, APTT, fibrinogen, D-dimer, and specialty coagulation factor assays, supporting thrombosis and hemostasis research and clinical monitoring. The company's UID (Urine Intelligent Data) urinalysis research platform provides particle classification capabilities beyond traditional manual urinalysis. Sysmex's partnership with Partec for flow cytometry technology adds cell sorting and immunophenotyping capabilities. Their informatics middleware Camelot-S integrates across analyzer platforms for data management in research networks.